Prof. Ng received his medical school training at the Chinese University of Hong Kong. Upon completion of his internship training, Prof. Ng joined the Department of Clinical Oncology at Prince of Wales Hospital in 1992 and later Pamela Youde Nethersole Eastern Hospital in 1994. He attained Fellow of the Royal College of Radiologists in 1997 and was conferred Doctor of Medicine at the University of Hong Kong in 2008.
Prof. Ng is currently the clinical professor at the University of Hong Kong, honorary consultant at the Hong Kong Sanatorium and Hospital, honorary consultant at the Pamela Youde Nethersole Eastern Hospital, honorary consultant at the Queen Mary Hospital, and past president of the Hong Kong Head and Neck Society. He also serves the editorial board of Oral Oncology and Journal of Hong Kong College of Radiologists; and was also a member of TNM Expert Advisory Panel on Head and Neck Cancers for the UICC. Over the years, Prof. Ng has been actively engaged in clinical research and has contributed to more than 100 publications. His main research interest is head and neck oncology.
2.Ng WT, Lee MCH, Fung NTC, Wong ECY, Cheung AKW, Chow JCH, Au KH, Poon DMC, Lai JWY, Chiang CL, Choi HCW, Chau TC, Lee VHF, Lee AWM. Dose Volume Effects of Re-irradiation for Locally Recurrent Nasopharyngeal Carcinoma. Head Neck 2020 Feb;42(2):180-187.
3.Lee AW, Ng WT, Pan JJ, Chiang CL, Poh SS, Choi HC, Chan Ahn Y, AlHussain H, Corry J, Grau C, Grégoire V, Harrington KJ, Hu CS, Kwong DL, Langendijk JA, Le QT, Lee NY, Lin JC, Lu TX, Mendenhall WM, O'Sullivan B, Ozyar E, Peters LJ, Rosenthal DI, Sanguineti G, Soong YL, Tao Y, Yom SS, Wee JT. Interrnational Guideline on Dose Prioritization and Acceptance Criteria in Radiotherapy Planning for Nasopharyngeal Carcinoma. Int J Radiat Oncol Biol Phys. 2019 Nov 1;105(3):567-580.
4.Ng WT, Wong ECY, Cheung AKW, Chow JCH, Poon DMC, Lai JWY, Chiang CL, Choi HCW, Chau TC, Lee VHF, Lee AWM, Tam AHP, Au KH. Patterns of care and treatment outcomes for local recurrence of NPC after definite IMRT – a study by the HKNPCSG. Head Neck 2019 Oct;41(10):3661-3669.
5.Lee AWM, Ng WT, Chan JYW, Corry J, Mäkitie A, Mendenhall WM, Rinaldo A, Rodrigo JP, Saba NF, Strojan P, Suárez C, Vermorken JB, Yom SS, Ferlito A. Management of locally recurrent nasopharyngeal carcinoma. Cancer Treat Rev. 2019 Sep;79:101890.
6.Ng WT, Tung SY, Lee V, Ngan RKC, Choi HCW, Chan LLK, Leung TW, Siu LL, Lu TX, Tan T, Tan EH, Sze HCK, Ng AWY, Yiu HHY, O'Sullivan B, Chappell R, Lee AWM. Concurrent-Adjuvant Chemoradiation Therapy for Stage III-IVB Nasopharyngeal Carcinoma-Exploration for Achieving Optimal 10-Year Therapeutic Ratio. Int J Radiat Oncol Biol Phys. 2018;101(5):1078-1086.
7.Ng WT, Ngan RK, Kwong DL, Tung SY, Yuen KT, Kam MK, Sze HC, Yiu HH, Chan LL, Lung ML, Lee AW. A prospective multicenter phase II trial of induction chemotherapy followed by bio-chemoradiotherapy for locally advanced recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2018 Mar 1;100(3):630-638.
8.Lee AW, Ng WT, Pan JJ, Poh SS, Ahn YC, AlHussain H, Corry J, Grau C, Grégoire V, Harrington KJ, Hu CS, Kwong DL, Langendijk JA, Le QT, Lee NY, Lin JC, Lu TX, Mendenhall WM, O'Sullivan B, Ozyar E, Peters LJ, Rosenthal DI, Soong YL, Tao Y, Yom SS, Wee JT. International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma. Radiother Oncol. 2018 Jan;126(1):25-36.
9.Ng WT, Wong ECY, Lee VHF, Chan JYW, Lee AWM. Head and neck cancer in Hong Kong. Jpn J Clin Oncol. 2018 Jan 1;48(1):13-21.
10.Lee AWM, Tung SY, Ng WT, Lee V, Ngan RKC, Choi HCW, Chan LLK, Siu LL, Ng AWY, Leung TW, Yiu HHY, O'Sullivan B, Chappell R. A multicentre, phase 3, randomized trial on concurrent chemoradiotherapy plus adjuvant chemotherapy versus radiotherapy alone in patients with regionally advanced nasopharyngeal carcinoma: 10-year outcome on efficacy and toxicity. Cancer 2017 Nov 1;123(21):4147-4157.
11.Rotolo F, Pignon JP, Bourhis J, Marguet S, Leclercq J, Ng WT, Ma J, Chan AT, Huang PY, Zhu G, Chua DT, Chen Y, Mai HQ, Kwong DL, Soong YL, Moon J, Tung Y, Chi KH, Fountzilas G, Zhang L, Hui EP, Lee AW, Blanchard P, Michiels S; MAC-NPC Collaborative Group. Surrogate endpoints for overall survival in loco-regionally advanced nasopharyngeal carcinoma: an individual data meta-analysis. J Natl Cancer Inst. 2017 Apr 1;109(4).
12.Ribassin-Majed L, Marguet S, Lee AW, Ng WT, Ma J, Chan AT, Huang PY, Zhu G, Chua DT, Chen Y, Mai HQ, Kwong DL, Cheah SL, Moon J, Tung Y, Chi KH, Fountzilas G, Bourhis J, Pignon JP, Blanchard P. What is the best treatment for locally advanced nasopharyngeal carcinoma? An individual patient data network meta-analysis. JCO 2017 Feb 10;35(5):498-505.
13.Pan JJ, Ng WT, Zong JF, Lee SW, Choi HC, Chan LL, Lin SJ, Guo QJ, Sze HC, Chen YB, Xiao YP, Kan WK, O'Sullivan B, Xu W, Le QT, Glastonbury CM, Colevas AD, Weber RS, Lydiatt W, Shah JP, Lee AW. Prognostic nomogram for refining the prognostication of the proposed 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy. Cancer 2016 Nov 15;122(21):3307-3315.
14.Blanchard P, Lee A, Marguet S, Leclercq J, Ng WT, Ma J, Chan AT, Huang PY, Benhamou E, Zhu G, Chua DT, Chen Y, Mai HQ, Kwong DL, Cheah SL, Moon J, Tung Y, Chi KH, Fountzilas G, Zhang L, Hui EP, Lu TX, Bourhis J, Pignon JP; MAC-NPC Collaborative Group. Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis. Lancet Oncol. 2015 Jun;16(6):645-55.
15.Lee AW, Ma BB, Ng WT, Chan AT. The management of nasopharyngeal carcinoma – current practice and future perspective. JCO 2015 Oct 10;33(29):3356-64.